Showing results (2611-2620 of 10,857) with videos related to
Sort By:
Pageof 1,086
Trials|June 9, 2023
Safety and efficacy in pediatric secondary intraocular lens implantation, in-the-bag versus sulcus implantation: a multicenter, single-blinded randomized controlled trialYingshi Zou, Ling Jin, Bo Qu, et al.Trials|June 12, 2023
Effect of interscalene brachial plexus block with dexmedetomidine and ropivacaine on postoperative analgesia in patients undergoing arthroscopic shoulder surgery: a randomized controlled clinical trialHengfei Luan, Conghui Hao, Han Li, et al.Trials|June 12, 2023
Effect of post-extubation high-flow nasal cannula combined with respiratory training versus conventional oxygen therapy on postoperative pulmonary complications in patients after major abdominal surgery: protocol for a single-centre randomized controlled trialBiao Jin, Mengjing Yao, Wenjuan Shen, et al.Trials|June 9, 2023
Protocol of a prospective multicenter randomized controlled trial of robot-assisted stereotactic lesioning in the treatment of focal drug-resistant epilepsyMingkun Gong, Ke Xu, Yongzhi Shan, et al.Trials|March 26, 2026
Supporting reanalysis and reuse of clinical trial data: a case studyCora Burgwinkel, Han Chang Chiam, Ka Hin Tai, et al.Trials|March 19, 2026
Protocol of a dyadic, app-supported collaborative care intervention trial for informal caregivers of people living with dementia-the multi-center living@home studyEva Gläser, Fabian Kleinke, Milena Armanowski, et al.Trials|March 21, 2026
Early childhood intervention for children at risk of developmental disabilities and their caregivers in Rwanda: study protocol for the PDC/Baby Ubuntu cluster randomised trialNathaniel Scherer, Mathieu Nemerimana, Carol Nanyunja, et al.Trials|April 26, 2026
Enhancing the scope of the Trials to Publications tool by identifying ClinicalTrial.gov registry mentions in full-textArthur W Holt, Neil R SmalheiserTrials|May 1, 2026
Ivermectin therapy is associated with changes in SARS-CoV-2 RNA load in asymptomatic patients: a randomized controlled trialHussein Mouawia, Hamid Bou Saab, Hassan Ayoub, et al.Trials|April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic riskPhyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.Pageof 1,086